home
portfolio
team
careers
contact
investor portal
home
portfolio
team
careers
contact
investor portal
Nextech Invest
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Kinnate Biopharma Inc. Announces FDA Clearance of Investigational Drug Application for KIN-3248
Post navigation
Previous Post
Previous
Scorpion Therapeutics Enters Agreement with Astrazeneca to Discover, Develop and Commercialize Novel Cancer Treatments Against Undruggable Targets
Next Post
Next
Amgen and Arrakis Therapeutics Announce Multi-Target Collaboration to Identify Novel RNA Degrader Small Molecule Therapeutics